Risperidone-induced reversible neutropenia

Vasanth Kattalai Kailasam, Victoria Chima, Uchechukwu Nnamdi, Kavita Sharma, Kairav Shah

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This case report presents a 44-year-old man with a history of schizophrenia who developed neutropenia on risperidone therapy. The patient’s laboratory reports showed a gradual decline of leukocytes and neutrophils after resolution and rechallenging. This was reversed with the discontinuation of risperidone and by switching to olanzapine. In this case report, we also discuss the updated evidence base for management of risperidone-induced neutropenia.

Original languageEnglish (US)
Pages (from-to)1975-1977
Number of pages3
JournalNeuropsychiatric Disease and Treatment
Volume13
DOIs
StatePublished - Jul 25 2017

Fingerprint

Risperidone
Neutropenia
olanzapine
Schizophrenia
Neutrophils
Leukocytes
Therapeutics

Keywords

  • Antipsychotics
  • Blood dyscrasias
  • Neutropenia
  • Risperidone

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Risperidone-induced reversible neutropenia. / Kailasam, Vasanth Kattalai; Chima, Victoria; Nnamdi, Uchechukwu; Sharma, Kavita; Shah, Kairav.

In: Neuropsychiatric Disease and Treatment, Vol. 13, 25.07.2017, p. 1975-1977.

Research output: Contribution to journalArticle

Kailasam, Vasanth Kattalai ; Chima, Victoria ; Nnamdi, Uchechukwu ; Sharma, Kavita ; Shah, Kairav. / Risperidone-induced reversible neutropenia. In: Neuropsychiatric Disease and Treatment. 2017 ; Vol. 13. pp. 1975-1977.
@article{1ee4d2721d4f43d4a4bb173d0ccea320,
title = "Risperidone-induced reversible neutropenia",
abstract = "This case report presents a 44-year-old man with a history of schizophrenia who developed neutropenia on risperidone therapy. The patient’s laboratory reports showed a gradual decline of leukocytes and neutrophils after resolution and rechallenging. This was reversed with the discontinuation of risperidone and by switching to olanzapine. In this case report, we also discuss the updated evidence base for management of risperidone-induced neutropenia.",
keywords = "Antipsychotics, Blood dyscrasias, Neutropenia, Risperidone",
author = "Kailasam, {Vasanth Kattalai} and Victoria Chima and Uchechukwu Nnamdi and Kavita Sharma and Kairav Shah",
year = "2017",
month = "7",
day = "25",
doi = "10.2147/NDT.S141472",
language = "English (US)",
volume = "13",
pages = "1975--1977",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Risperidone-induced reversible neutropenia

AU - Kailasam, Vasanth Kattalai

AU - Chima, Victoria

AU - Nnamdi, Uchechukwu

AU - Sharma, Kavita

AU - Shah, Kairav

PY - 2017/7/25

Y1 - 2017/7/25

N2 - This case report presents a 44-year-old man with a history of schizophrenia who developed neutropenia on risperidone therapy. The patient’s laboratory reports showed a gradual decline of leukocytes and neutrophils after resolution and rechallenging. This was reversed with the discontinuation of risperidone and by switching to olanzapine. In this case report, we also discuss the updated evidence base for management of risperidone-induced neutropenia.

AB - This case report presents a 44-year-old man with a history of schizophrenia who developed neutropenia on risperidone therapy. The patient’s laboratory reports showed a gradual decline of leukocytes and neutrophils after resolution and rechallenging. This was reversed with the discontinuation of risperidone and by switching to olanzapine. In this case report, we also discuss the updated evidence base for management of risperidone-induced neutropenia.

KW - Antipsychotics

KW - Blood dyscrasias

KW - Neutropenia

KW - Risperidone

UR - http://www.scopus.com/inward/record.url?scp=85026647905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026647905&partnerID=8YFLogxK

U2 - 10.2147/NDT.S141472

DO - 10.2147/NDT.S141472

M3 - Article

AN - SCOPUS:85026647905

VL - 13

SP - 1975

EP - 1977

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

ER -